Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and MPTP Neurotoxicity Syndrome

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with MPTP Neurotoxicity Syndrome in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Research Excerpts

ExcerptRelevanceReference
" MPTP-treated mice maintained at 4 degrees C demonstrated (1) a greater hypothermic response, (2) a significant reduction in striatal DA content and tyrosine hydroxylase (TH) activity, and (3) significantly greater striatal 1-methyl-4-phenylpyridinium (MPP+) levels, as compared to mice dosed with MPTP at room temperature."1.30Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice. ( Albers, DS; Moy, LY; Sonsalla, PK, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moy, LY1
Albers, DS1
Sonsalla, PK1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and MPTP Neurotoxicity Syndrome

ArticleYear
Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.
    Brain research, 1998, Apr-20, Volume: 790, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 8-Hydroxy-2-(di-n-propyla

1998